Chinese, Israeli companies team up to build COVID-19 testing facility
The lab will be able to perform over 10,000 tests per day and is expected to be completed by April 9.
An employee of German biopharmaceutical company CureVac, demonstrates research workflow on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany(photo credit: REUTERS/ANDREAS GEBERT)
